Management of hypertension

Area of Science:

• Cardiology
• Pharmacology
• Internal Medicine

Background:

• Numerous antihypertensive drug classes exist for managing high blood pressure.
• Clinical trials have generally not demonstrated significant differences in patient prognosis among major drug classes.
• Patient comorbidities and specific characteristics influence treatment decisions.

Purpose of the Study:

• To review the comparative effectiveness of different antihypertensive drug classes.
• To identify potential differences in adverse event profiles, specifically the incidence of new-onset diabetes mellitus.
• To emphasize the importance of individualized treatment selection in hypertension management.

Main Methods:

• Review of prospective clinical trials comparing various antihypertensive drug classes.
• Analysis of data regarding overall patient prognosis and specific adverse events.
• Consideration of patient-specific factors in treatment selection.

Main Results:

• Major antihypertensive drug classes show comparable overall prognostic outcomes.
• Angiotensin-converting enzyme (ACE) inhibitors, AT1 receptor blockers, and calcium entry blockers may be associated with a lower incidence of new-onset diabetes mellitus compared to diuretics.
• Many patients require multiple antihypertensive medications despite initial therapeutic considerations.

Conclusions:

• The choice of antihypertensive therapy should be individualized, considering patient comorbidities.
• While overall prognosis is similar, specific drug classes may offer advantages regarding certain adverse outcomes like diabetes development.
• Combination therapy is frequently necessary for effective blood pressure control.